Latest News
-
Latest findings on managing osteoarthritis
Posted on:
If you’re looking for the best advice for osteoarthritis care, have a listen to one of our leading clinicians and Kolling Institute researchers Professor David Hunter as he highlights the most effective treatment approaches and the low-value ones to avoid. Thank you to Dr Norman Swan and the team at the ABC’s Health Report for the
Category:
-
Epic journey to support vital rheumatoid arthritis research
Posted on:
The burble of high-powered motorcycles was heard across the Kolling Institute forecourt as part of a 2000 kilometre ride from Melbourne to Armidale to raise awareness and funds for life-changing research. The ride is an initiative of Robert Hunt from the Ulysses Club which has been supporting rheumatoid arthritis research for nearly three decades. The
Category:
-
Prestigious grant for groundbreaking blood cancer research at the Kolling
Posted on:
A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Associate Professor Jenny Wang to progress her vital cancer research. As the head of the Kolling Institute’s Cancer and Stem Cell Laboratory, Associate Professor Wang has secured a $2.95 million investigator grant from the National Health and Medical Research Council to
Category:
-
New trial to determine if diet and exercise alone can prevent knee osteoarthritis
Posted on:
In one of the first global clinical trials of its kind, researchers have launched a study to investigate if a diet and exercise program aimed at weight loss can prevent the development of crippling knee osteoarthritis. The trial will be led by researchers from the University of Sydney and the Kolling Institute in collaboration with
Category:
-
The Kolling hosts the brightest minds in optogenetics
Posted on:
More than 80 top national and international scientists converged on the Kolling Institute for the 4th Optogenetics Australia meeting, featuring the very latest light technologies driving research. The event attracted dynamic keynote speakers from the USA, Europe and China, and leading research institutions across Australia. Chair of Optogenetics Australia and senior Kolling Institute pain medicine
-
Researchers identify new gene linked to Meniere’s disease
Posted on:
In a crucial step towards a better understanding of Meniere’s disease, researchers at the Kolling Institute and the University of Sydney have discovered a gene mutation which could greatly inform future treatment of the disease. Meniere’s is a rare inner ear disease associated with sensorineural hearing loss, vertigo and debilitating tinnitus. There is currently no
-
roundbreaking work in geriatric pharmacology
Posted on:
For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has
-
Top pain specialist and researcher receives Australia Day gong
Posted on:
Internationally respected clinical academic Professor Paul Glare has been named a Member of the Order of Australia for his significant service to medicine in the fields of pain management and palliative care. Professor Glare is a specialist physician in pain medicine and senior researcher with the Kolling Institute. He is the Director of the Michael
Category:
-
Clinical Trials Champion
Posted on:
As a clinical trials program lead at the Kolling Institute, Dr Karen Bracken has long been driven to help researchers conduct trials in the best way possible. “Researchers are passionate about their disease area and their patients, and they have so many unanswered questions,” she says. Karen comes from a family of clinicians, and while
Category:
-
Next generation of researchers streamlining complex medication choices
Posted on:
Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is